Value-Based Payment Experiments For Drugs To Be Key Focus For CMMI, Director Says
Executive Summary
Recently-installed Center for Medicare and Medicaid Innovation Chief Adam Boehler says payment lab will play a role in the Administration’s overall approach to lowering prescription drug costs.
You may also be interested in...
City Of Hope's Joseph Alvarnas On CAR-T Real-World Use, Reimbursement
City of Hope hematologist/oncologist Joseph Alvarnas shares his perspectives on how CAR-T therapies are requiring new models of health care delivery and engagement with more kinds of stakeholders, during an interview at the recent ASH annual meeting.
HHS Secretary Alex Azar Talks Rebate Changes, But Not Eliminating Discounts Altogether
Details on anticipated changes to rebate practices are in demand. HHS Secretary Azar talked about changes that would still allow negotiated discounts at the point of sale during a presentation at the FT Pharma Pricing and Value Summit.
HHS Secretary Alex Azar Talks Rebate Changes, But Not Eliminating Discounts Altogether
Details on anticipated changes to rebate practices are in demand. HHS Secretary Azar talked about changes that would still allow negotiated discounts at the point of sale during a presentation at the FT Pharma Pricing and Value Summit.